Targeting Lrig1 on the surface of Treg cell in the periphery alleviates the symptoms of Alzheimer’s Disease in vivo
Sang‐Kyou Lee · 2025
Read Targeting Lrig1 on the surface of Treg cell in the periphery alleviates the symptoms of Alzheimer’s Disease in vivo by Sang‐Kyou Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11712777.txt.
Description
Sang-Kyou Lee reports that an antibody aimed at a protein on regulatory T cells eased Alzheimer's symptoms in mice, in a 2025 study. The protein, Lrig1, is concentrated on Treg cells, which calm the immune system. Lee's team injected the antibody, called GTC 310-01, into two genetic mouse models of Alzheimer's disease and tracked memory and brain changes.
Treated mice did better on three memory tests, and their brains held less amyloid and tau buildup. The antibody first dialed down Treg activity, which let immune cells from the blood enter the brain and clear the deposits. Treg numbers in the brain later rose and settled the inflammation. Lee proposes this peripheral immune route as a new treatment idea.
Catalog record
| CREATOR | Sang‐Kyou Lee |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |